Clinical trial
Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil…
NCT00478205 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00478205 |
|---|---|
| Title | Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease |
| Official title | Double-Blind, Parallel-Group Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease |
| Lead sponsor | Eisai Inc., Industry |
| Collaborators | Eisai Limited Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | Aricept (donepezil SR 23 mg), Aricept (donepezil IR 10 mg) |
| Enrollment | 1,467 |
| Start date | Jun 1, 2007 |
| Primary completion | Jun 1, 2009 |
| First posted | May 24, 2007 |
| Last update posted | Jul 11, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: